Pharmacogenetics: Technologies to detect copy number variations

Current Opinion in Molecular Therapeutics

Volumn 11, Issue 6, 2009, Pages 670-680

  Dhawan, Dipali ^a   Padh, Harish ^a  

^a B V PATEL PHARMACEUTICAL EDUCATION AND RESEARCH DEVELOPMENT PERD CENTRE   (India)

Author keywords

Copy number variation; Drug response; Genomic variation; Pharmacogenetic; Technique

Indexed keywords

CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GEFITINIB; GLUTATHIONE TRANSFERASE P1; METHOTREXATE; NUCLEOTIDE;

COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; DNA MICROARRAY; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE AMPLIFICATION; GENE DELETION; GENE DUPLICATION; GENE INSERTION; GENE NUMBER; GENE STRUCTURE; GENETIC VARIABILITY; GENOME; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MULTIPLEX POLYMERASE CHAIN REACTION; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; PUBLICATION; PULSED FIELD GEL ELECTROPHORESIS; QUANTITATIVE ANALYSIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTHERN BLOTTING; TANDEM REPEAT; TECHNOLOGY;

BLOTTING, SOUTHERN; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; DNA COPY NUMBER VARIATIONS; GENETIC VARIATION; GENOME, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MICROARRAY ANALYSIS; PHARMACOGENETICS; POLYMERASE CHAIN REACTION;

EID: 72449160153     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Feuk L, Carson AR, Scherer SW: Structural variation in the human genome. Nat Rev Genet (2006) 7(2):85-97.
2. Weber JL, David D, Heil J, Fan Y, Zhao C, Marth G: Human diallelic insertion/deletion polymorphisms. Am J Hum Genet (2002) 71(4):854-862.
3. Bhangale TR, Rieder MJ, Livingston RJ, Nickerson DA: Comprehensive identification and characterization of diallelic insertion-deletion polymorphisms in 330 human candidate genes. Hum Mol Genet (2005) 14(1):59-69.
4. Mills RE, Luttig CT, Larkins CE, Beauchamp A, Tsui C, Pittard WS, Devine SE: An initial map of insertion and deletion (INDEL) variation in the human genome. Genome Res (2006) 16(9): 1182-1190.
5. Feuk L, Marshal CR, Wintle RF, Scherer SW: Structural variants: Changing the landscape of chromosomes and design of disease studies. Hum Mol Genet (2006) 15(1):R57-R66.
6. Freeman JL, Perry GH, Feuk L, Redon R, McCarroll SA, Altshuler DM, Aburatani H, Jones KW, Tyler-Smith C, Hurles ME, Carter NP et al: Copy number variation: New insights in genome diversity. Genome Res (2006) 16(8):949-961. (Pubitemid 44162254)
7. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, Fiegler H, Shapero MH, Carson AR, Chen W, Cho EK et al: Global variation in copy number in the human genome. Nature (2006) 444(7118):444-454. (Pubitemid 44809057)
8. Conrad DF, Hurles ME: The population genetics of structural variation. Nat Genet (2007) 39(7 Suppl):S30-S36.
9. Wong KK, deLeeuw RJ, Dosanjh NS, Kimm LR, Cheng Z, Horsman DE, MacAulay C, Ng RT, Brown CJ, Eichler EE, Lam WL: A comprehensive analysis of common copy-number variations in the human genome. Am J Hum Genet (2007) 80(1):91-104.
10. Eichler EE, Nickerson DA, Altshuler D, Bowcock AM, Brooks LD, Carter NP, Church DM, Felsenfeld A, Guyer M, Lee C, Lupski JR et al: Completing the map of human genetic variation. Nature (2007) 447(7141):161-165.
11. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y, Scherer SW, Lee C: Detection of large-scale variation in the human genome. Nat Genet (2004) 36(9):949-951.
12. Sebat J, Lakshmi B, Troge J, Alexander J, Young J, Lundin P, Månér S, Massa H, Walker M, Chi M, Navin N et al: Large-scale copy number polymorphism in the human genome. Science (2004) 305(5683):525-528.
13. Tuzun E, Sharp AJ, Bailey JA, Kaul R, Morrison VA, Pertz LM, Haugen E, Hayden H, Albertson D, Pinkel D, Olson MV et al: Finescale structural variation of the human genome. Nat Genet (2005) 37(7):727-732.
14. Conrad DF, Andrews TD, Carter NP, Hurles ME, Pritchard JK: A high-resolution survey of detection polymorphism in the human genome. Nat Genet (2006) 38(1):75-81.
15. McCarroll SA, Hadnott TN, Perry GH, Sabeti PC, Zody MC, Barrett JC, Dallaire S, Gabriel SB, Lee C, Daly MJ, Altshuler DM et al: Common deletion polymorphisms in the human genome. Nat Genet (2006) 38(1):86-92.
16. Khaja R, Zhang J, MacDonald JR, He Y, Joseph-George AM, Wei J, Rafiq MA, Qian C, Shago M, Pantano L, Aburatani H et al: Genome assembly comparison identifies structural variants in the human genome. Nat Genet (2006) 38(12): 1413-1418.
17. Chauhan N, Rani S, Padh H: Pharmacogenetics: Genetic basis for rational drug therapy. Indian J Pharm Sci (2007) 69(2): 180-189.
18. Van Prooijen-Knegt AC, Van Hoek JF, Bauman JG, Van Duijn P, Wool IG, Van der Ploeg M: In situ hybridization of DNA sequences in human metaphase chromosomes visualized by an indirect fluorescent immunocytochemical procedure. Exp Cell Res (1982) 141(2):397-407.
19. Kris MG, Natale RB, Herbst RS, Lynch TJ Jr, Prager D, Belani CP, Schiller JH, Kelly K, Spiridonidis H, Sandler A, Albain KS et al: Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: A randomized trial. JAMA (2003) 290(16):2149-2158. (Pubitemid 37432975)
20. Pugh TJ, Bebb G, Barclay L, Sutcliffe M, Fee J, Salski C, O'Connor R, Ho C, Murray N, Melosky B, English J et al: Correlations of EGFR mutations and increases in EGFR and HER2 copy number to gefitinib response in a retrospective analysis of lung cancer patients. BMC Cancer (2007) 7:128.
21. Cullen KJ, Kenneth AN, Schumaker LM, Aldosari N, Rone JD, Haddad BR: Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors. Cancer Res (2003) 63(23):8097-8102.
22. Leach TJ, Glaser RL: Quantitative hybridization to genomic DNA fractionated by pulsed-field gel electrophoresis. Nucleic Acids Res (1998) 26(20):4787-4789.
23. Akervall JA, Michalides RJ, Mineta H, Balm A, Borg A, Dictor MR, Jin Y, Loftus B, Mertens F, Wennerberg JP: Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognosis value of chromosomal abnormalities and cyclin D1 overexpression. Cancer (Phila) (1997) 79(2):380-389.
24. Kalish LH, Kwong RA, Cole IE, Gallagher RM, Sutherland RL, Musgrove EA: Deregulated cyclin D1 expression is associated with decreased efficacy of the selective epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in head and neck squamous cell carcinoma cell lines. Clin Cancer Res (2004) 10(22):7764-7774.
25. Pratesi G, Dal Bo L, Paolicchi A, Tonarelli P, Tongiani R, Zunino F: The role of the glutathione-dependent system in tumor sensitivity to cisplatin: A study of human tumor xenografts. Ann Oncol (1995) 6(3):283-289.
26. Yellin SA, Davidson BJ, Pinto JT, Sacks PG, Qiao C, Schantz SP: Relationship of glutathione and glutathione-S-transferase to cisplatin sensitivity in human head and neck squamous carcinoma cell lines. Cancer Lett (1994) 85(2):223-232.
27. Daly AK: Pharmacogenetics. In: Handbook of drug metabolism. Woolf TF (Ed), Marcel Dekker Inc, New York, NY, USA (1999):175-202.
28. McLellan RA, Oscarson M, Alexandrie AK, Seidegård J, Evans DA, Rannug A, Ingelman-Sundberg M: Characterization of a human glutathione S-transferase mu cluster containing a duplicated GSTM1 gene that causes ultrarapid enzyme activity. Mol Pharmacol (1997) 52(6):958-965.
29. Kauffman FC: Sulfonation in pharmacology and toxicology. Drug Metab Rev (2004) 36(3-4):823-843.
30. Hebbring SJ, Adjei AA, Baer JL, Jenkins GD, Zhang J, Cunningham JM, Schaid DJ, Weinshilboum RM, Thibodeau SN: Human SULT1A1 gene: Copy number differences and functional implications. Hum Mol Genet (2007) 16(5): 463-470.
31. Kallioniemi OP, Kallioniemi A, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D: Comparative genomic hybridization: A rapid new method for detecting and mapping DNA amplification in tumors. Semin Cancer Biol (1993) 4(1):41-46.
32. Kallioniemi A, Visakorpi T, Karhu R, Pinkel D, Kallioniemi OP: Gene copy number analysis by fluorescence in situ hybridization and comparative genomic hybridization. Methods (1996) 9(1):113-121.
33. Lucito R, Healy J, Alexander J, Reiner A, Esposito D, Chi M, Rodgers L, Brady A, Sebat J, Troge J, West JA et al: Representational oligonucleotide microarray analysis: A high-resolution method to detect genome copy number variation. Genome Res (2003) 13(10):2291-2305.
34. Kennedy GC, Matsuzaki H, Dong S, Liu WM, Huang J, Liu G, Su X, Cao M, Chen W, Zhang J, Liu W et al: Large-scale genotyping of complex DNA. Nat Biotechnol (2003) 21(10):1233-1237.
35. Zhao X, Li C, Paez JG, Chin K, Jänne PA, Chen TH, Girard L, Minna J, Christiani D, Leo C, Gray JW et al: An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res (2004) 64(9):3060-3071.
36. Slater HR, Bailey DK, Ren H, Cao M, Bell K, Nasioulas S, Henke R, Choo KH, Kennedy GC: High-resolution identification of chromosomal abnormalities using oligonucleotide arrays containing 116,204 SNPs. Am J Hum Genet (2005) 77(5): 709-726.
37. Huang J, Wei W, Zhang J, Liu G, Bignell GR, Stratton MR, Futreal PA, Wooster R, Jones KW, Shapero MH: Whole genome DNA copy number changes identified by density oligonucleotide arrays. Hum Genomics (2004) 1(4): 287-299.
38. Bignell GR, Huang J, Greshock J, Watt S, Butler A, West S, Grigorova M, Jones KW, Wei W, Stratton MR, Futreal PA et al: High-resolution analysis of DNA copy number using oligonucleotide microarrays. Genome Res (2004) 14(2):287-295.
39. Affymetrix: Affymetrix Inc, Santa Clara, CA, USA (2009). www. affymetrix.com
40. Illumina: Illumina, San Diego, CA, USA (2009). www.illumina.com
41. Schiff R, Massarweh S, Shou J, Osborne CK: Breast cancer endocrine resistance: How growth factor signaling and estrogen receptor coregulators modulate response. Clin Cancer Res (2003) 9(1 Pt 2):447S-454S. (Pubitemid 36105786)
42. Han W, Han MR, Kang JJ, Bae JY, Lee JH, Bae YJ, Lee JE, Shin HJ, Hwang KT, Hwang SE, Kim SW et al: Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer. BMC Cancer (2006) 6:92.
43. Hattinger CM, Reverter-Branchat G, Remondini D, Castellani GC, Benini S, Pasello M, Manara MC, Scotlandi K, Picci P, Serra M: Genomic imbalances associated with methotrexate resistance in human osteosarcoma cell lines detected by comparative genomic hybridization-based techniques. Eur J Cell Biol (2003) 82(9):483-493.
44. Stankiewicz P, Beaudet AL: Use of array CGH in the evaluation of dysmorphology, malformations, developmental delay and idiopathic mental retardation. Curr Opin Genet Dev (2007) 17(3):182-192.
45. Armour JA, Sismani C, Patsalis PC, Cross G: Measurement of locus copy number by hybridisation with amplifiable probes. Nucleic Acids Res (2000) 28(2):605-609.
46. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G: Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res (2002) 30(12):e57.
47. Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, Gianni L, Baselga J, Bell R, Jackisch C, Cameron D et al: Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. NEJM (2005) 353(16): 1659-1672. (Pubitemid 41464705)
48. Moerland E, van Hezik RL, van der Aa TC, van Beek MW, van den Brule AJ: Detection of HER2 amplification in breast carcinomas: Comparison of Multiplex Ligation-dependent Probe Amplification (MLPA) and Fluorescence In Situ Hybridization (FISH) combined with automated spot counting. Cell Oncol (2006) 28(4): 151-159.
49. Fridlyand J, Snijders A, Pinkel A, Albertson D, Jain A: Hidden Markov models approach to the analysis of array CGH data. J Multivar Anal (2004) 90(1):132-153.
50. Colella S, Yau C, Taylor JM, Mirza G, Butler H, Clouston P, Bassett AS, Seller A, Holmes CC, Ragoussis J: QuantiSNP: An Objective Bayes Hidden-Markov Model to detect and accurately map copy number variation using SNP genotyping data. Nucleic Acids Res (2007) 35(6):2013-2025.
51. Olshen AB, Venkatraman ES, Lucito R, Wigler M: Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics (2004) 5(4):557-572.
52. Korbel JO, Urban AE, Grubert F, Du J, Royce TE, Starr P, Zhong G, Emanuel BS, Weissman SM, Snyder M, Gerstein MB: Systematic prediction and validation of breakpoints associated with copynumber variants in the human genome. Proc Natl Acad Sci USA (2007) 104(24):10110-10115.
53. Levy S, Sutton G, Ng PC, Feuk L, Halpern AL, Walenz BP, Axelrod N, Huang J, Kirkness EF, Denisov G, Lin Y et al: The diploid genome sequence of an individual human. PloS Biol (2007) 5(10):e254.
54. Bentley DR, Balasubramanian S, Swerdlow HP, Smith GP, Milton J, Brown CG, Hall KP, Evers DJ, Barnes CL, Bignell HR, Boutell JM et al: Accurate whole human genome sequencing using reversible terminator chemistry. Nature (2008) 456(7218):53-59.
55. Wang J, Wang W, Li R, Li Y, Tian G, Goodman L, Fan W, Zhang J, Li J, Zhang J, Guo Y et al: The diploid genome sequence of an Asian individual. Nature (2008) 456(7218):60-65.
56. Ahn SM, Kim TH, Lee S, Kim D, Ghang H, Kim DS, Kim BC, Kim SY, Kim WY, Kim C, Park D et al: The first Korean genome sequence and analysis: Full genome sequencing for a socio-ethnic group. Genome Res (2009) 19(9):1622-1629.
57. Database of Genomic Variants: MaRS Centre, Toronto, ON, Canada (2009). projects.tcag.ca/variation.
58. Scherer SW, Lee C, Birney E, Altshuler DM, Eichler EE, Carter NP, Hurles ME, Feuk L: Challenges and standards in integrating surveys of structural variation. Nat Genet (2007) 39 (7 Suppl):S7-S15.
59. DECIPHER database: Wellcome Trust Genome Campus, Cambridge, UK (2009). decipher.sanger.ac.uk.
60. Chen FC, Chen YZ, Chuang TJ: CNVVdb: A database of copy number variations across vertebrate genomes. Bioinformatics (2009) 25(11):1419-1421.
61. Nguyen D, Webber C, Ponting CP: Bias of selection on human copy-number variants. PloS Genet (2006) 2(2):e20.
62. Dhami P, Coffey AJ, Abbs S, Vermeesch JR, Dumanski JP, Woodward KJ, Andrews RM, Langford C, Vetrie D: Exon array CGH: Detection of copy number changes at the resolution of individual exons in the human genome. Am J Hum Genet (2005) 76(5):750-762.
63. Companion diagnostics gaining ground, but slowly: BioWorld Today, Atlanta, GA, USA (2008). www.bioworld.com/servlet/ com.accumedia.web.Dispatcher? next=bioWorldHeadlines-article&forceid=47846.
64. DxS Diagnostics: DxS Ltd, Manchester, UK (2009). www. dxsdiagnostics.com.
65. Almac: Almac Diagnostics, Craigavon, UK (2009). www.almacgroup. com/diagnostics/cancer-dsa.aspx.
66. Sharp AJ, Locke DP, McGrath SD, Cheng Z, Bailey JA, Vallente RU, Pertz LM, Clark RA, Schwartz S, Segraves R, Oseroff VV et al: Segmental duplications and copy-number variation in the human genome. Am J Hum Genet (2005) 77(1):78-88. (Pubitemid 40848038)
67. Stefansson H, Helgason A, Thorleifsson G, Steinthorsdottir V, Masson G, Barnard J, Baker A, Jonasdottir A, Ingason A, Gudnadottir VG, Desnica N et al: A common inversion under selection in Europeans. Nat Genet (2005) 37(2): 129-137.
68. Visser R, Shimokawa O, Harada N, Kinoshita A, Ohta T, Niikawa N, Matsumoto N: Identification of a 3.0-kb major recombination hotspot in patients with sotos syndrome who carry a common 1.9-Mb microdeletion. Am J Hum Genet (2005) 76(1):52-67.